Raifarm Kazakhstan successfully completed Tracleer registration in Kazakhstan. Tracleer is an effective treatment of Pulmonary Arterial Hypertension (PAH). PAH is an orphan disease (it occurs in 1 case per 500 000 population).  The registration confirms our status of leading professionals on orphan medications in Kazakhstan.